| Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia P Ganesan, TG Sagar, B Dubashi, R Rajendranath, K Kannan, S Cyriac, ... American journal of hematology 86 (6), 471-474, 2011 | 157 | 2011 |
| Clinicopathological analysis and outcome of primary mediastinal malignancies—a report of 91 cases from a single institute B Dubashi, S Cyriac, SG Tenali Annals of thoracic medicine 4 (3), 140, 2009 | 61 | 2009 |
| Quality of life among young women with breast cancer: Study from a tertiary cancer institute in south India B Dubashi, E Vidhubala, S Cyriac, TG Sagar Indian journal of cancer 47 (2), 142, 2010 | 47 | 2010 |
| Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level? S Kodidela, PS Chandra, B Dubashi European journal of clinical pharmacology 70 (3), 253-260, 2014 | 31 | 2014 |
| Rituximab induced myocardial infarction: a fatal drug reaction P Arunprasath, P Gobu, B Dubashi, S Satheesh, J Balachander Journal of cancer research and therapeutics 7 (3), 346, 2011 | 30 | 2011 |
| Clinical presentation and outcome of pediatric ovarian germ cell tumor: a study of 40 patients D Biswajit, CN Patil, TG Sagar Journal of pediatric hematology/oncology 32 (2), e54-e56, 2010 | 26 | 2010 |
| Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A> G) and rs442767 (-680C> A) on the outcome of methotrexate-based maintenance therapy in South Indian … S Kodidela, SC Pradhan, B Dubashi, D Basu European journal of clinical pharmacology 71 (11), 1349-1358, 2015 | 17 | 2015 |
| Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib J Francis, B Dubashi, R Sundaram, SC Pradhan, A Chandrasekaran Medical Oncology 32 (8), 213, 2015 | 17 | 2015 |
| Prescription errors in cancer chemotherapy: Omissions supersede potentially harmful errors J Mathaiyan, T Jain, B Dubashi, KS Reddy, G Batmanabane Journal of pharmacology & pharmacotherapeutics 6 (2), 83, 2015 | 17 | 2015 |
| Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis ZP Jiang, XL Zhao, N Takahashi, S Angelini, B Dubashi, L Sun, P Xu Pharmacogenomics 18 (1), 35-56, 2017 | 12 | 2017 |
| A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced … J Francis, B Dubashi, R Sundaram, SC Pradhan, A Chandrasekaran Cancer chemotherapy and pharmacology 76 (6), 1185-1189, 2015 | 12 | 2015 |
| Weekly paclitaxel in ovarian cancer—the latest success story A Jain, B Dubashi, KS Reddy, P Jain Current Oncology 18 (1), 16, 2011 | 12 | 2011 |
| Prescription, transcription and administration errors in out-patient day care unit of a regional cancer centre in South India J Mathaiyan, T Jain, B Dubashi, G Batmanabane Asian Pac J Cancer Prev 17, 2611-2617, 2016 | 10 | 2016 |
| A rare case of adult acute lymphoblastic leukemia presenting with paraparesis and multiple osteolytic lesions SP Verma, B Dubashi, D Basu, TK Dutta, R Kar Indian Journal of Hematology and Blood Transfusion 30 (1), 24-26, 2014 | 10 | 2014 |
| Docetaxel-induced hand foot syndrome:" No dose is a safe dose". A Jain, B Dubashi Journal of pharmacology & pharmacotherapeutics 3 (2), 2012 | 10 | 2012 |
| Mesentric gastrointestinal stromal tumor with bone metastases A Jain, B Dubashi, S Chandra, D Halanaik Indian journal of cancer 48 (3), 383, 2011 | 10 | 2011 |
| l-Asparginase induced cortical venous thrombosis in a patient with acute leukemia B Dubashi, A Jain Journal of pharmacology & pharmacotherapeutics 3 (2), 194, 2012 | 9 | 2012 |
| Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study J Francis, M Palaniappan, B Dubashi, SC Pradhan, A Chandrasekaran Journal of pharmacology & pharmacotherapeutics 6 (1), 30, 2015 | 8 | 2015 |
| Frequency distribution of DNA repair genes ERCC1 and ERCC2 polymorphisms in South Indian healthy population KS Rao, S SureshKumar, G Umamaheswaran, A Paul, B Dubashi, ... Environmental toxicology and pharmacology 38 (2), 480-488, 2014 | 7 | 2014 |
| Tumor lysis syndrome in multiple myeloma treated with bortezomib KM Dhanraj, D Biswajit Journal of pharmacology & pharmacotherapeutics 5 (2), 161, 2014 | 7 | 2014 |
